Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 68151-68200 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06104085
99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer
NARecruiting
30 participants
Started: Sep 13, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06259669
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
N/ARecruiting
958 participants
Started: Sep 13, 2023 · Completed: Aug 1, 2033
2 conditions1 sponsor1 location
NCT05377905
Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)
PHASE1/PHASE2Recruiting
48 participants
Started: Sep 13, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT05882734
Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)
PHASE1/PHASE2Active, not recruiting
61 participants
Started: Sep 13, 2023 · Completed: Mar 30, 2026
1 condition2 sponsors54 locations
NCT06121245
The PRO-SOma COla (PROSOCO) Study
NARecruiting
11 participants
Started: Sep 13, 2023 · Completed: Feb 29, 2024
1 condition2 sponsors2 locations
NCT06276816
Cardiac Denervation Ablation Strategy for Severe Sinus Bradycardia
N/ARecruiting
88 participants
Started: Sep 13, 2023 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT06317467
Role of Anti-C1q Autoantibodies in Pregnancy
N/ARecruiting
54 participants
Started: Sep 13, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06074341
TeleHealth Resources for IndiVidualizEd Goals (THRIVE) in Alcohol Recovery Study
NAActive, not recruiting
470 participants
Started: Sep 13, 2023 · Completed: Jul 31, 2028
3 conditions2 sponsors1 location
NCT06036056
NMR Based Metabolomics Kinetics in ARDS Patients
N/ARecruiting
120 participants
Started: Sep 13, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT06019624
Fresh Takes!: An Evaluation of the Impact of Receiving Fresh Food Boxes
NARecruiting
400 participants
Started: Sep 13, 2023 · Completed: Jun 30, 2027
3 conditions2 sponsors1 location
NCT05779735
"Validation of Ultrasound Angle of Progression Measurement to Decrease the Cesarean Rate"
NARecruiting
182 participants
Started: Sep 13, 2023 · Completed: Oct 13, 2025
1 condition1 sponsor7 locations
NCT05797805
A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma
PHASE1/PHASE2Recruiting
178 participants
Started: Sep 13, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor8 locations
NCT05648097
Baldachin: Ceiling HEPA-filtration to Prevent Nosocomial Transmission of COVID-19
NARecruiting
104 participants
Started: Sep 13, 2023 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT06221579
An Intergenerational, Cognitively Enriched Intervention for MCI Patients and Their Children.
NAEnrolling by invitation
15 participants
Started: Sep 13, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT06029218
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
NARecruiting
106 participants
Started: Sep 13, 2023 · Completed: Oct 1, 2031
4 conditions1 sponsor1 location
NCT06036394
Artificial Intelligence in CNS Radiation Oncology
N/ARecruiting
6,000 participants
Started: Sep 13, 2023 · Completed: Sep 30, 2028
1 condition2 sponsors1 location
NCT05846087
Mobile App-delivered Sleep Therapy (SleepFix) for Individuals With Chronic Low Back Pain and Insomnia
NARecruiting
178 participants
Started: Sep 13, 2023 · Completed: May 31, 2025
2 conditions3 sponsors1 location
NCT06533878
Evaluate Tolerability and Safety of HY209 in Healthy Volunteers
PHASE1Enrolling by invitation
59 participants
Started: Sep 13, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06081686
Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer
PHASE1/PHASE2Recruiting
32 participants
Started: Sep 13, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT06144671
GT201 Injection For The Treatment Of Advanced Solid Tumors
PHASE1/PHASE2Recruiting
18 participants
Started: Sep 13, 2023 · Completed: Sep 13, 2026
1 condition1 sponsor4 locations
NCT05864248
Feasibility Study SA of the Supira System for HRPCI
NARecruiting
115 participants
Started: Sep 13, 2023 · Completed: Sep 30, 2025
3 conditions1 sponsor2 locations
NCT05842512
Study of ADI-PEG 20 Versus Placebo in Subjects With NASH
PHASE2Recruiting
60 participants
Started: Sep 13, 2023 · Completed: Jan 31, 2028
1 condition1 sponsor10 locations
NCT05912777
3D Reconstruction of the Knee Based on MRI
NARecruiting
50 participants
Started: Sep 13, 2023 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT06287684
Molecular Subtype-Specific Mechanisms and Therapeutic Strategies in Sepsis
N/ARecruiting
460 participants
Started: Sep 13, 2023 · Completed: Dec 30, 2028
2 conditions2 sponsors1 location
NCT06068400
Clinical Study to Evaluate the Safety and Efficacy of CAR-T in the Treatment of Multiple Myeloma
NARecruiting
40 participants
Started: Sep 13, 2023 · Completed: May 31, 2029
1 condition1 sponsor1 location
NCT06052397
Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium
N/ARecruiting
150 participants
Started: Sep 12, 2023 · Completed: Sep 30, 2027
3 conditions1 sponsor1 location
NCT05573893
PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan
N/ARecruiting
800 participants
Started: Sep 12, 2023 · Completed: Dec 31, 2031
3 conditions2 sponsors102 locations
NCT06461793
Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H)
PHASE2Recruiting
33 participants
Started: Sep 12, 2023 · Completed: Dec 31, 2033
1 condition1 sponsor1 location
NCT06784583
A Study on Transcutaneous Vagus Nerve Stimulation in Perioperative Period of Percutaneous Coronary Intervention
NARecruiting
494 participants
Started: Sep 12, 2023 · Completed: Jun 1, 2025
2 conditions1 sponsor1 location
NCT06051214
Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients At Risk
NARecruiting
200 participants
Started: Sep 12, 2023 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT05817175
International Prospective REgistry on Pre-pectorAl Breast REconstruction
N/ARecruiting
1,236 participants
Started: Sep 12, 2023 · Completed: Sep 10, 2027
1 condition2 sponsors11 locations
NCT06030388
Strength and Aerobic Training Against Hot Flushes in Postmenopausal Women
NARecruiting
90 participants
Started: Sep 12, 2023 · Completed: Dec 31, 2032
2 conditions3 sponsors2 locations
NCT06028672
Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6
NARecruiting
40 participants
Started: Sep 12, 2023 · Completed: Aug 31, 2025
1 condition10 sponsors1 location
NCT06146816
The Assessment of Infrared Treatment for Crohn's Disease
NARecruiting
40 participants
Started: Sep 12, 2023 · Completed: Apr 30, 2026
3 conditions1 sponsor1 location
NCT06040827
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension
N/ARecruiting
626 participants
Started: Sep 12, 2023 · Completed: Dec 31, 2028
1 condition2 sponsors7 locations
NCT06830551
The Effect of Cord Blood Serum Eyes Drops Administer in Patients With Severe Keratopathy Related to EGFR-I Treatment
NARecruiting
10 participants
Started: Sep 12, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06008626
Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea
NARecruiting
25 participants
Started: Sep 12, 2023 · Completed: Mar 31, 2028
1 condition1 sponsor5 locations
NCT06043700
A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology
N/AActive, not recruiting
2,000 participants
Started: Sep 12, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor3 locations
NCT06030804
Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery
NARecruiting
4,532 participants
Started: Sep 12, 2023 · Completed: Oct 31, 2028
4 conditions2 sponsors39 locations
NCT06194838
Clinical Outcomes With Non-Powered vs. Powered Prosthetic Knees by K2-level Amputees
NARecruiting
26 participants
Started: Sep 12, 2023 · Completed: Aug 31, 2026
6 conditions2 sponsors1 location
NCT05721560
SINEFIX-2022 Pilot Phase
NAActive, not recruiting
9 participants
Started: Sep 12, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT06033547
A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Two Different Formulations of Long-acting Cabotegravir in Healthy Adult Participants
PHASE1Active, not recruiting
56 participants
Started: Sep 12, 2023 · Completed: May 13, 2027
1 condition1 sponsor1 location
NCT06017947
Evaluation of a Musical Intervention on the Anxiety of Patients With a Diagnosis of Acute Coronary Syndrome in a Pre-Hospital Emergency Situation: MuSCA Randomized Controlled Trial
NARecruiting
92 participants
Started: Sep 12, 2023 · Completed: Jun 11, 2026
1 condition1 sponsor1 location
NCT06150313
Efficacy of the Mediational Intervention for Sensitizing Caregivers for Teachers and Self-Administered Versions
NARecruiting
105 participants
Started: Sep 12, 2023 · Completed: Feb 2, 2025
1 condition2 sponsors1 location
NCT05896891
San Raffaele EoE Biobank
N/ANot yet recruiting
500 participants
Started: Sep 12, 2023 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT05805007
Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis Pigmentosa
EARLY_PHASE1Recruiting
9 participants
Started: Sep 12, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT06053190
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
NARecruiting
80 participants
Started: Sep 12, 2023 · Completed: Mar 1, 2025
3 conditions1 sponsor1 location
NCT06051188
FCV vs PCV in Moderate to Severe ARDS
NARecruiting
28 participants
Started: Sep 12, 2023 · Completed: May 31, 2026
2 conditions2 sponsors1 location
NCT05926583
A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa
PHASE3Recruiting
4 participants
Started: Sep 12, 2023 · Completed: Nov 12, 2030
1 condition1 sponsor1 location
NCT06067867
Kidney and Pregnancy Registry
N/ARecruiting
600 participants
Started: Sep 12, 2023 · Completed: Dec 31, 2043
1 condition1 sponsor1 location